Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cepacol is a commercial brand of antiseptic mouthwash primarily utilized for oral hygiene. Its active ingredient, cetylpyridinium chloride, confers broad-spectrum antimicrobial properties, effectively reducing the viability of various oral microorganisms, including bacteria such as Streptococcus mutans, Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa, as well as fungi like Candida albicans and Candida glabrata. Cepacol is employed for controlling biofilm formation on oral prostheses, disinfecting toothbrushes, and as an adjunct to routine oral care to prevent oral diseases and enamel demineralization. Some formulations may also include fluoride and ethanol.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cepacol.